PADMED LAXAN cpr 60 pce

7680574780176 CH-57478 A06AB20
PADMED LAXAN cpr 60 pce
PADMED LAXAN cpr 60 pce
PADMED LAXAN cpr 60 pce
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
12.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIIS
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
35.0 MG Substance Wirkstoff (Principe actif)
(N/A)
35.0 MG Substance Wirkstoff (Principe actif)
(N/A)
35.0 MG Substance Wirkstoff (Principe actif)
(N/A)
15.0 MG Substance Wirkstoff (Principe actif)
(N/A)
35.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.5 MG Substance Wirkstoff (Principe actif)
(N/A)
52.5 MG Substance Wirkstoff (Principe actif)
(N/A)
52.5 MG Substance Wirkstoff (Principe actif)
(N/A)
70.0 MG Substance Wirkstoff (Principe actif)
(N/A)
1.75 MG Substance Wirkstoff (Principe actif)
(N/A)
70.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

PADMA AG

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
57478
Drug name
Padmed Laxan, Tabletten
Galenic form
TAB
ATC Code
A06AB20
Authorization status
Revoked/Withdrawn
Authorization category
Category C
Dispensation category
B
First authorization
15/06/2005
Authorization expiration date
01/04/2025
IT number
20.03.2.
Domain
Human medicine
Field of application
Nach den Therapieprinzipien der Tibetischen Medizin bei Verstopfung

Packaging details

Description (FR)
PADMED LAXAN cpr 60 pce
Description (DE)
PADMED LAXAN Tabl 60 Stk
Market launch
15/06/2005
Market withdrawal
01/04/2025
Narcotic (BTM)
No

Other packaging sizes